‘Magic Mushroom’ Company Goes Mainstream, Jumps 71% Post-IPO
Compass Pathways Plc, the U.K. company that has patented a synthetic version of the active ingredient in so-called magic mushrooms for use in treatment-resistant depression, went public on Friday.
bloomberg.com